Remote Monitoring in Idiopathic Pulmonary Fibrosis: Home Is Where the Bluetooth-enabled Spirometer Is.
作者信息
Johannson Kerri A
机构信息
Department of Medicineand.
Department of Community Health SciencesUniversity of CalgaryCalgary, Alberta, Canada.
出版信息
Am J Respir Crit Care Med. 2020 Aug 1;202(3):316-317. doi: 10.1164/rccm.202005-1532ED.
Abstract
摘要
相似文献
1
Remote Monitoring in Idiopathic Pulmonary Fibrosis: Home Is Where the Bluetooth-enabled Spirometer Is.特发性肺纤维化的远程监测：家就是配备蓝牙的肺活量计所在之处。
Am J Respir Crit Care Med. 2020 Aug 1;202(3):316-317. doi: 10.1164/rccm.202005-1532ED.
2
Utilizing a Homecare Platform for Remote Monitoring of Patients with Idiopathic Pulmonary Fibrosis.利用家庭护理平台对特发性肺纤维化患者进行远程监测。
Adv Exp Med Biol. 2017;989:177-187. doi: 10.1007/978-3-319-57348-9_15.
3
A home monitoring program including real-time wireless home spirometry in idiopathic pulmonary fibrosis: a pilot study on experiences and barriers.特发性肺纤维化患者家庭监测方案：实时无线家庭肺功能测定的试点研究——经验与障碍
Respir Res. 2018 May 29;19(1):105. doi: 10.1186/s12931-018-0810-3.
4
Use of the patientMpower App With Home-Based Spirometry to Monitor the Symptoms and Impact of Fibrotic Lung Conditions: Longitudinal Observational Study.使用 patientMpower 应用程序进行家庭肺功能测定以监测肺纤维化症状和影响：纵向观察研究。
JMIR Mhealth Uhealth. 2020 Nov 20;8(11):e16158. doi: 10.2196/16158.
5
Home spirometry in patients with idiopathic pulmonary fibrosis: data from the INMARK trial.特发性肺纤维化患者的家庭肺量计检查：INMARK 试验的数据。
Eur Respir J. 2021 Jul 8;58(1). doi: 10.1183/13993003.01518-2020. Print 2021 Jul.
6
Home Monitoring in Patients with Idiopathic Pulmonary Fibrosis. A Randomized Controlled Trial.特发性肺纤维化患者的家庭监测。一项随机对照试验。
Am J Respir Crit Care Med. 2020 Aug 1;202(3):393-401. doi: 10.1164/rccm.202002-0328OC.
7
Lung function testing in idiopathic pulmonary fibrosis: More than just spirometry?特发性肺纤维化的肺功能测试：仅仅是肺活量测定吗？
Arch Bronconeumol. 2016 Sep;52(9):457-8. doi: 10.1016/j.arbres.2016.02.017. Epub 2016 Apr 14.
8
Home spirometry for idiopathic pulmonary fibrosis: ready for prime time?用于特发性肺纤维化的家庭肺量计：准备好进入黄金时代了吗？
Eur Respir J. 2017 Jul 20;50(1). doi: 10.1183/13993003.01403-2017. Print 2017 Jul.
9
Home monitoring improves endpoint efficiency in idiopathic pulmonary fibrosis.家庭监测可提高特发性肺纤维化的终点效率。
Eur Respir J. 2017 Jul 5;50(1). doi: 10.1183/13993003.02406-2016. Print 2017 Jul.
10
Using forced vital capacity (FVC) in the clinic to monitor patients with idiopathic pulmonary fibrosis (IPF): pros and cons.用用力肺活量（FVC）在临床上监测特发性肺纤维化（IPF）患者：利弊。
Expert Rev Respir Med. 2021 Feb;15(2):175-181. doi: 10.1080/17476348.2020.1816831. Epub 2020 Sep 28.
引用本文的文献
1
European ILD registry algorithm for self-assessment in interstitial lung diseases (eurILDreg ASA-ILD).欧洲间质性肺疾病自我评估注册算法（eurILDreg ASA-ILD）
PLoS One. 2025 Jan 29;20(1):e0316484. doi: 10.1371/journal.pone.0316484. eCollection 2025.
2
Protocol and research program of the European registry and biobank for interstitial lung diseases (eurILDreg).欧洲间质性肺病注册和生物库研究方案 (eurILDreg)。
BMC Pulm Med. 2024 Nov 18;24(1):572. doi: 10.1186/s12890-024-03389-9.
3
Feasibility and acceptability of remotely monitoring spirometry and pulse oximetry as part of interstitial lung disease clinical care: a single arm observational study.远程监测肺量计和脉搏血氧饱和度作为间质性肺疾病临床护理一部分的可行性和可接受性：一项单臂观察性研究。
Respir Res. 2024 Apr 15;25(1):162. doi: 10.1186/s12931-024-02787-1.
4
REMOTE-ILD study: Description of the protocol for a multicentre, 12-month randomised controlled trial to assess the clinical and cost-effectiveness of remote monitoring of spirometry and pulse oximetry in patients with interstitial lung disease.远程ILD 研究：一项多中心、12 个月随机对照试验的方案描述，旨在评估远程监测间质性肺疾病患者的肺量计和脉搏血氧饱和度的临床和成本效益。
BMJ Open Respir Res. 2024 Feb 28;11(1):e002067. doi: 10.1136/bmjresp-2023-002067.
5
Worldwide experiences and opinions of healthcare providers on eHealth for patients with interstitial lung diseases in the COVID-19 era.全球医疗服务提供者对COVID-19时代间质性肺疾病患者电子健康的经验与看法。
ERJ Open Res. 2021 Aug 31;7(3). doi: 10.1183/23120541.00405-2021. eCollection 2021 Jul.
6
Patient-centered Outcomes Research in Interstitial Lung Disease: An Official American Thoracic Society Research Statement.以患者为中心的间质性肺疾病结局研究：美国胸科学会官方研究声明。
Am J Respir Crit Care Med. 2021 Jul 15;204(2):e3-e23. doi: 10.1164/rccm.202105-1193ST.
7
Update in Interstitial Lung Disease 2020.2020年间质性肺疾病进展
Am J Respir Crit Care Med. 2021 Jun 1;203(11):1343-1352. doi: 10.1164/rccm.202103-0559UP.
8
Home monitoring for patients with ILD and the COVID-19 pandemic.间质性肺病患者的居家监测与新冠疫情
Lancet Respir Med. 2020 Dec;8(12):1172-1174. doi: 10.1016/S2213-2600(20)30452-5. Epub 2020 Oct 16.
本文引用的文献
1
Practical Considerations for the Diagnosis and Treatment of Fibrotic Interstitial Lung Disease During the Coronavirus Disease 2019 Pandemic.COVID-19 大流行期间纤维化间质性肺疾病的诊断和治疗的实际考虑。
Chest. 2020 Sep;158(3):1069-1078. doi: 10.1016/j.chest.2020.04.019. Epub 2020 Apr 22.
2
Home Monitoring in Patients with Idiopathic Pulmonary Fibrosis. A Randomized Controlled Trial.特发性肺纤维化患者的家庭监测。一项随机对照试验。
Am J Respir Crit Care Med. 2020 Aug 1;202(3):393-401. doi: 10.1164/rccm.202002-0328OC.
3
Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial.吡非尼酮治疗无法分类的进行性纤维化间质性肺疾病患者：一项双盲、随机、安慰剂对照、2 期临床试验。
Lancet Respir Med. 2020 Feb;8(2):147-157. doi: 10.1016/S2213-2600(19)30341-8. Epub 2019 Sep 29.
4
Mobile Health Monitoring in Patients with Idiopathic Pulmonary Fibrosis.特发性肺纤维化患者的移动健康监测
Ann Am Thorac Soc. 2019 Oct;16(10):1327-1329. doi: 10.1513/AnnalsATS.201904-335RL.
5
A home monitoring program including real-time wireless home spirometry in idiopathic pulmonary fibrosis: a pilot study on experiences and barriers.特发性肺纤维化患者家庭监测方案：实时无线家庭肺功能测定的试点研究——经验与障碍
Respir Res. 2018 May 29;19(1):105. doi: 10.1186/s12931-018-0810-3.
6
Home spirometry in bronchiolitis obliterans after allogeneic haematopoietic cell transplant.异基因造血细胞移植后闭塞性细支气管炎的家庭肺量计检查
Eur Respir J. 2018 Jul 19;52(1). doi: 10.1183/13993003.02328-2017. Print 2018 Jul.
7
Air Pollution Exposure Is Associated With Lower Lung Function, but Not Changes in Lung Function, in Patients With Idiopathic Pulmonary Fibrosis.空气污染暴露与特发性肺纤维化患者的肺功能下降相关，但与肺功能变化无关。
Chest. 2018 Jul;154(1):119-125. doi: 10.1016/j.chest.2018.01.015. Epub 2018 Feb 7.
8
Daily home spirometry to detect early steroid treatment effects in newly treated pulmonary sarcoidosis.采用每日家庭肺量计检测新治疗的结节病患者早期类固醇治疗效果。
Eur Respir J. 2018 Jan 18;51(1). doi: 10.1183/13993003.02089-2017. Print 2018 Jan.
9
Physical activity and activity space in patients with pulmonary fibrosis not prescribed supplemental oxygen.非吸氧肺纤维化患者的体力活动和活动空间。
BMC Pulm Med. 2017 Nov 23;17(1):154. doi: 10.1186/s12890-017-0495-2.
10
Home monitoring improves endpoint efficiency in idiopathic pulmonary fibrosis.家庭监测可提高特发性肺纤维化的终点效率。
Eur Respir J. 2017 Jul 5;50(1). doi: 10.1183/13993003.02406-2016. Print 2017 Jul.
Zotero 插件